• Topical steroids

Pandel Generic Name & Formulations

General Description

Hydrocortisone probutate 0.1%; crm.

Pharmacological Class


How Supplied

Crm—45g, 80g


Pandel Indications


Corticosteroid-responsive dermatoses.

Pandel Dosage and Administration


≥18yrs: apply thin film to affected area 1–2 times daily. Discontinue when control is achieved. Reassess if no improvement within 2 weeks.


<18yrs: not established.

Pandel Contraindications

Not Applicable

Pandel Boxed Warnings

Not Applicable

Pandel Warnings/Precautions


Avoid near or around eyes, face, underarms, groin areas. Occlude only if necessary. Not for diaper dermatitis; do not use in diaper area. Evaluate for HPA axis suppression periodically (esp. in prolonged use, application to large surface area, use of occlusive dressings, impaired skin, or in children); discontinue or reduce dose or potency if occurs. Hepatic impairment. Diabetes. Discontinue if irritation develops. Avoid abrupt cessation. Pregnancy. Nursing mothers: use on the smallest area of skin for the shortest duration.

Pandel Pharmacokinetics

See Literature

Pandel Interactions

Pandel Adverse Reactions

Adverse Reactions

Burning, stinging, rash, redness, itching, paresthesia, contact dermatitis; HPA axis suppression (esp. in children), Cushing's syndrome, hyperglycemia, skin atrophy, secondary infections.

Pandel Clinical Trials

See Literature

Pandel Note

Not Applicable

Pandel Patient Counseling

See Literature